Evidence map›Paper›PMID 23629723›Full record

ArticleAntimicrobial agents and chemotherapy2013

Decreased vancomycin susceptibility in Staphylococcus aureus caused by IS256 tempering of WalKR expression.

Christopher R E McEvoy, Brian Tsuji, Wei Gao, Torsten Seemann, Jessica L Porter, Kenneth Doig, Dung Ngo, Benjamin P Howden, Timothy P Stinear

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Gausemycin A-ResistantMicroorganisms · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Vancomycin resistantJournal of advanced research · 2020
    Review
  13. Article
  14. Review
  15. Genome-Based Prediction of Bacterial Antibiotic Resistance.Journal of clinical microbiology · 2019
    Review
  16. ISFrontiers in microbiology · 2019
    Article
  17. Review
  18. Article
  19. Reconstruction of the Vancomycin-SusceptibleFrontiers in microbiology · 2018
    Article
  20. Bacterial genome sequencing in clinical microbiology: a pathogen-oriented review.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Christopher R E McEvoyDepartment of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia.
Brian Tsuji
Wei Gao
Torsten Seemann
Jessica L Porter
Kenneth Doig
Dung Ngo
Benjamin P Howden
Timothy P Stinear
University of Melbourne · AUUniversity at Buffalo, State University of New York · USAustin Health · AUMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vancomycin-intermediate Staphylococcus aureus (VISA) strains often arise by mutations in the essential two-component regulator walKR; however their impact on walKR function has not been definitively established. Here, we investigated 10 MRSA strains recovered serially after exposure of vancomycin-susceptible S. aureus (VSSA) JKD6009 to simulated human vancomycin dosing regimens (500 mg to 4,000 mg every 12 h) using a 10-day hollow fiber infection model. After continued exposure to the vancomycin regimens, two isolates displayed reduced susceptibility to both vancomycin and daptomycin, developing independent IS256 insertions in the walKR 5' untranslated region (5' UTR). Quantitative reverse transcription-PCR (RT-PCR) revealed a 50% reduction in walKR gene expression in the IS256 mutants compared to the VSSA parent. Green fluorescent protein (GFP) reporter analysis, promoter mapping, and site-directed mutagenesis confirmed these findings and showed that the IS256 insertions had replaced two SigA-like walKR promoters with weaker, hybrid promoters. Removal of IS256 reverted the phenotype to VSSA, showing that reduced expression of WalKR did induce the VISA phenotype. Analysis of selected WalKR-regulated autolysins revealed upregulation of ssaA but no change in expression of sak and sceD in both IS256 mutants. Whole-genome sequencing of the two mutants revealed an additional IS256 insertion within agrC for one mutant, and we confirmed that this mutation abolished agr function. These data provide the first substantial analysis of walKR promoter function and show that prolonged vancomycin exposure can result in VISA through an IS256-mediated reduction in walKR expression; however, the mechanisms by which this occurs remain to be determined.

Indexed as

DNA Transposable ElementsAnti-Bacterial AgentsBacterial ProteinsBase SequenceDaptomycinDNA, BacterialGene Expression Regulation, BacterialGenome, BacterialMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMolecular Sequence DataMutagenesis, InsertionalMutagenesis, Site-DirectedPeptidoglycan GlycosyltransferasePromoter Regions, GeneticProtein KinasesAgrC protein, StaphylococcusAnti-Bacterial AgentsBacterial ProteinsDaptomycinDNA, BacterialDNA Transposable ElementsPeptidoglycan GlycosyltransferaseProtein KinasesSceD protein, Staphylococcus aureusVancomycin

Identifiers

PMID23629723
PMCPMC3697332
OpenAlexW2139150940

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.